CapsoVision, Inc Cost of Revenue
CapsoVision, Inc (CV) reported Cost of Revenue of $1.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-13
- CapsoVision, Inc cost of goods and services sold for the quarter ending 2026-06-30 was $1.77M, a 17.82% increase year-over-year.
- CapsoVision, Inc cost of goods and services sold for the quarter ending 2026-03-31 was $1.46M, a 13.50% increase year-over-year.
- CapsoVision, Inc cost of goods and services sold for the quarter ending 2025-12-31 was $1.96M, a 14.32% increase year-over-year.
- CapsoVision, Inc cost of goods and services sold for the quarter ending 2025-09-30 was $1.62M, a 24.06% increase year-over-year.
- CapsoVision, Inc cost of goods and services sold for fiscal 2025 was $6.38M, a 18.63% increase from fiscal 2024.
- CapsoVision, Inc cost of goods and services sold for fiscal 2024 was $5.38M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.77M 10-Q · filed 2026-08-13 | $3.23M 10-Q · filed 2026-08-13 | $5.20M derived: sum of 3 quarters · filed 2026-08-13 | $6.82M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.46M 10-Q · filed 2026-05-14 | $3.43M derived: sum of 2 quarters · filed 2026-05-14 | $5.05M derived: sum of 3 quarters · filed 2026-05-14 | $6.55M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $3.59M derived: sum of 2 quarters · filed 2026-03-26 | $5.09M derived: sum of 3 quarters · filed 2026-08-13 | $6.38M 10-K · filed 2026-03-26 |
| 2025-09-30 | $1.62M 10-Q · filed 2025-11-13 | $3.13M derived: sum of 2 quarters · filed 2026-08-13 | $4.42M 10-Q · filed 2025-11-13 | $6.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.50M 10-Q · filed 2026-08-13 | $2.79M 10-Q · filed 2026-08-13 | $4.51M derived: sum of 3 quarters · filed 2026-08-13 | $5.82M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.29M 10-Q · filed 2026-05-14 | $3.01M derived: sum of 2 quarters · filed 2026-05-14 | $4.32M derived: sum of 3 quarters · filed 2026-05-14 | $5.57M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $3.03M derived: sum of 2 quarters · filed 2026-03-26 | $4.28M derived: sum of 3 quarters · filed 2026-03-26 | $5.38M 10-K · filed 2026-03-26 |
| 2024-09-30 | $1.31M 10-Q · filed 2025-11-13 | $2.56M derived: sum of 2 quarters · filed 2025-11-13 | $3.66M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.25M 10-Q · filed 2025-08-14 | $2.35M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |